Insulin Drugs Global Market Expected to Grow with a CAGR of 7% Over the Forecast Period, 2019-2023 -

DUBLIN--()--The "Insulin Drugs Global Market Report 2020" report has been added to's offering.

The global insulin drugs market was valued at about $25.44 billion in 2019 and is expected to grow to $29.39 billion at a CAGR of 7% through 2023.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.


  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The insulin drugs market section of the report gives context. It compares the insulin drugs market with other segments of the insulin drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, insulin drugs indicators comparison.


  • Markets Covered: 1) By Product Type: Basal or Long Acting Insulins; Bolus or Fast-Acting Insulins; Traditional Human Insulins; Combination Insulins; Biosimilar Insulins 2) By Application: Type II Diabetes; Type I Diabetes; Gestational Diabetes; Prediabetes
  • Time series: Five years historic and forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.
  • Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Key Topics Covered:

1. Executive Summary

2. Insulin Drugs Market Characteristics

3. Insulin Drugs Market Size And Growth

3.1. Global Insulin Drugs Historic Market, 2015 - 2019, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Insulin Drugs Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Insulin Drugs Market Segmentation

4.1. Global Insulin Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billio

4.2. Global Insulin Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5. Insulin Drugs Market Regional And Country Analysis

5.1. Global Insulin Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5.2. Global Insulin Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Insulin Drugs Market

7. China Insulin Drugs Market

8. India Insulin Drugs Market

9. Japan Insulin Drugs Market

10. Australia Insulin Drugs Market

11. Indonesia Insulin Drugs Market

12. South Korea Insulin Drugs Market

13. Western Europe Insulin Drugs Market

14. UK Insulin Drugs Market

15. Germany Insulin Drugs Market

16. France Insulin Drugs Market

17. Eastern Europe Insulin Drugs Market

18. Russia Insulin Drugs Market

19. North America Insulin Drugs Market

20. USA Insulin Drugs Market

21. South America Insulin Drugs Market

22. Brazil Insulin Drugs Market

23. Middle East Insulin Drugs Market

24. Africa Insulin Drugs Market

25. Insulin Drugs Market Competitive Landscape And Company Profiles

25.1. Insulin Drugs Market Competitive Landscape

25.2. Insulin Drugs Market Company Profiles

25.2.1. Apidra

25.2.2. Eli Lilly

25.2.3. Humalog

25.2.4. Humulin

25.2.5. Insuman

26. Key Mergers And Acquisitions In The Insulin Drugs Market

27. Insulin Drugs Market Trends And Strategies

28. Insulin Drugs Market Future Outlook and Potential Analysis

Companies Mentioned

  • Apidra
  • Eli Lilly
  • Humalog
  • Humulin
  • Insuman
  • Lantus
  • Levemir
  • Novo Nordisk
  • Novomix
  • NovoRapid/Novolog
  • Actrapid
  • Admelog
  • Novolin/Actrapid/Insulatard
  • Ryzodeg
  • Sanofi
  • Soliqua/Suliqua
  • Toujeo
  • Tresiba
  • Xultophy

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900